About: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2002 (uk) im August 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2002 (ast) scientific article published on 01 August 2002 (en)
publication date	wds:Q74487230-981E62A1-05BD-4ADC-A9C6-657FD1BF8DD7
publication date	2002-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74487230-182327C1-A974-44C2-9611-57A23EFF56D6
language of work or name	English
cites work	wds:Q74487230-0A1C4BDF-C2D1-4E2E-ACD1-2EFC0F5C9EE8 wds:Q74487230-0CE79133-D92D-4CDC-8B97-5EEEAF66F189 wds:Q74487230-103E5B2B-71E3-4381-BF63-FAB0560241B3 wds:Q74487230-122EB2CB-EFF8-4FC0-9E7D-BFE0E7A7D1D9 wds:Q74487230-430C2E9D-2624-4289-B8FE-218735C7DFF9 wds:Q74487230-46DB7471-DC9A-408A-9423-1D4AA35EE6AF wds:Q74487230-4C06FFCE-2E07-453A-81EA-0C4F854FAAE2 wds:Q74487230-4E6345B0-346C-4708-A537-2E91C78A0106 wds:Q74487230-53F518A8-30AF-43DC-9E03-8E9DF8D0C9B7 wds:Q74487230-57B650C4-36F4-4747-BF1C-DAACCC96ED10 wds:Q74487230-5AF31473-8D4E-4FE3-92A5-123A5DFA9EB9 wds:Q74487230-6557156A-BE09-47F0-9709-07DEE37230F3 wds:Q74487230-6C939B46-5410-47AE-9496-6931D836A94A wds:Q74487230-78522D03-C28C-4D50-BE43-8E456CB7FA73 wds:Q74487230-79D306BF-A941-411B-B877-E995789D9561 wds:Q74487230-7FB1B340-44DB-455B-9F3D-A2AE9E21B2E4 wds:Q74487230-85C9E8EF-7234-4DDA-8F9E-1E9547C5661E wds:Q74487230-8E9D57AC-D36D-4D29-A455-5217CFB30A78 wds:Q74487230-90AB10AF-121A-47EF-8176-86F2BBC6857C wds:Q74487230-9286639C-BF87-4E03-93EA-DCFD99F3F5F2 wds:Q74487230-93AAFB8F-15A5-40ED-8AC0-FC0E4BC79C0C wds:Q74487230-A11AD8B2-BB7F-455C-B4B3-4135318A5343 wds:Q74487230-A72ED84C-2B5C-45B7-8A7A-BB7E30D1C090 wds:Q74487230-C7A18630-22CA-4DC0-AB17-F7C4E5BC60D5 wds:Q74487230-D99BEDE6-EF4A-4A75-9253-D3E5453941B8 wds:Q74487230-DE4BF124-35FC-43F0-AFE1-3326EC86E9A9 wds:Q74487230-F04FFC33-310D-400A-A671-35494628E8BC wds:Q74487230-F5595A64-4317-483B-89EB-F72B0D8C957A wds:Q74487230-FBC4ED39-938D-48E7-847C-3CDE2809BBD0
cites work	Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10) External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. The effect of dose on local control of prostate cancer. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice External beam radiotherapy dose response of prostate cancer Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected]
author name string	wds:Q74487230-6B6C1F96-329C-4C6E-9F17-90DC2635F5C0 wds:Q74487230-70370D85-8CA8-4F93-A6BD-8409439D4313 wds:Q74487230-7703F0C9-FDBB-40AE-9C2E-0FBB821DD70D wds:Q74487230-AC6DA431-5B68-4D47-89BE-D8BFF17788B5 wds:Q74487230-BE5629C2-D1DB-4E7F-A9C2-4E65148D77C1 wds:Q74487230-C6D003F5-01CE-40CD-AD75-ABFCCCCB7A0E
author name string	J Jack Lee Alan Pollack George Starkschall Gunar K Zagars Isaac Rosen Eugene Huang
rdfs:label	Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (en) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (nl)
skos:prefLabel	Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (en) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (nl)
name	Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (en) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (nl)
author	wds:Q74487230-3FBC42D7-2050-4D93-947C-42E6E1A03790 wds:Q74487230-CD4653E1-73EE-416B-AD63-305658CC268B wds:Q74487230-FAD93599-E117-4D25-9197-305C10F9C887
author	Andrew C. von Eschenbach Deborah Kuban John A. Antolak
title	wds:Q74487230-68E3A803-5E5B-409B-BE1D-B8F822507FEF
title	Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial (en)
page(s)	wds:Q74487230-CECBC646-FA79-4F64-ACFF-6E3B3CD8EF9D
page(s)	1097-1105
instance of	wds:Q74487230-7A14065F-7E7C-4E2E-8BE1-C542D20BA271
instance of	scholarly article
main subject	wds:Q74487230-99F5A8ED-4CC1-4990-B779-98F65F4981AE wds:Q74487230-A479EAD7-266B-480F-B545-B8A796D3603E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software